Takuto Itano

2PUBLICATIONS
3CO-AUTHORS
Molecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 21, 2026
Osimertinib inhibits the MYLK4-mediated phosphorylation of CDKAL1 to suppress stemness and chemoresistance in rhabdomyosarcoma.

Takuto Itano, Rongsheng Huang, Toshifumi Ozaki

|Feb 25, 2025
Radiographic and Clinical Assessment of Unidirectional Porous Beta-Tricalcium Phosphate to Treat Benign Bone Tumors.

Toshiyuki Kunisada, Eiji Nakata, Tomohiro Fujiwara

Pageof 1